Waverley Pharma Inc V.WAVE

Healthcare Biotechnology

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. Its primary focus is the PARP-1 program and secondary focus is the generic oncology injectable market in European Union, the United Kingdom (UK) and North America. It has entered into a license, manufacture, supply, marketing and distribution agreement with Reliance Life Sciences Private Limited, which has granted it an exclusive territorial license to market and sell capecitabine in the UK and Germany as well as a non-exclusive territorial license to market and sell temozolomide and erlotinib in the UK. Its generic oncology products include bortezomib and pemetrexed. Bortezomib is an injectable generic chemotherapy drug, developed for the treatment of multiple myeloma and mantle cell lymphoma. Pemetrexed is an injectable generic chemotherapy drug, developed for the treatment of non-small cell lung cancer and pleural mesothelioma.

TSXV:WAVE - Post by User

Waverley Pharma Inc > Question...to anyone

<< Previous

Bullboard Posts

Next >>

Comment by Peytolakeon Feb 22, 2021 10:34am

154 Views

Post# 32625724

RE:RE:RE:Question...to anyone

This management doesn't exist! I ask me, what they are doing the whole day? In 5 weeks no development/progress in nothing! In 7 months no progress in the COVID Programm. In 5 months no progress in the term sheet of six additional products? Unbelievable and a big disappointment!

why we don't get an update about the progress of the different issues which are running? Why? So busy, no chance to update the shareholders! It's disappointed!!!

<< Previous

Bullboard Posts

Next >>

REITS over single property investments